Ausgewählte Publikationen
2023
- Haferkamp U., Hartmann C., Abid C. L., Brachner A., Höchner A., Gerhartl A., Harwardt B., Leckzik S., Leu J., Metzger M., Nastainczyk-Wulf M., Neuhaus W., Oerter S., Pless O., Rujescu D., Jung M. T., & Appelt-Menzel A. (2023). "Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease." Fluids and Barriers of the Cns, 20(1). doi:10.1186/s12987-023-00471-y
2022
- Krasemann S., Haferkamp U., Pfefferle S., Woo M. S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., Hartmann K., Thies E., Littau J. L., Sepulveda-Falla D., Zhang L., Ton K., Liang Y., Matschke J., Ricklefs F., Sauvigny T., Sperhake J., Fitzek A., Gerhartl A., Brachner A., Geiger N., König E.-M., Bodem J., Franzenburg S., Franke A., Moese S., Müller F.-J., Geisslinger G., Claussen C., Kannt A., Zaliani A., Gribbon P., Ondruschka B., Neuhaus W., Friese M. A., Glatzel M., & Pless O. (2022). "The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2." Stem Cell Reports, 17(2), 307-320. doi:10.1016/j.stemcr.2021.12.011
- Zink A., Haferkamp U., Wittich A., Beller M., Pless O., & Prigione A. (2022). "High-content screening of mitochondrial polarization in neural cells derived from human pluripotent stem cells." STAR Protocols, 3(3), 101602. doi:10.1016/j.xpro.2022.101602